4RNJ
PaMorA phosphodiesterase domain, apo form
Summary for 4RNJ
| Entry DOI | 10.2210/pdb4rnj/pdb |
| Related | 4RNF 4RNH 4RNI |
| Descriptor | Motility regulator (2 entities in total) |
| Functional Keywords | eal domain, phosphodiesterase, c-di-gmp, hydrolase |
| Biological source | Pseudomonas aeruginosa PAO1 |
| Total number of polymer chains | 2 |
| Total formula weight | 63454.64 |
| Authors | Phippen, C.W.,Tews, I. (deposition date: 2014-10-24, release date: 2014-11-19, Last modification date: 2023-09-20) |
| Primary citation | Phippen, C.W.,Mikolajek, H.,Schlaefli, H.G.,Keevil, C.W.,Webb, J.S.,Tews, I. Formation and dimerization of the phosphodiesterase active site of the Pseudomonas aeruginosa MorA, a bi-functional c-di-GMP regulator. Febs Lett., 588:4631-4636, 2014 Cited by PubMed Abstract: Diguanylate cyclases (DGC) and phosphodiesterases (PDE), respectively synthesise and hydrolyse the secondary messenger cyclic dimeric GMP (c-di-GMP), and both activities are often found in a single protein. Intracellular c-di-GMP levels in turn regulate bacterial motility, virulence and biofilm formation. We report the first structure of a tandem DGC-PDE fragment, in which the catalytic domains are shown to be active. Two phosphodiesterase states are distinguished by active site formation. The structures, in the presence or absence of c-di-GMP, suggest that dimerisation and binding pocket formation are linked, with dimerisation being required for catalytic activity. An understanding of PDE activation is important, as biofilm dispersal via c-di-GMP hydrolysis has therapeutic effects on chronic infections. PubMed: 25447517DOI: 10.1016/j.febslet.2014.11.002 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.32 Å) |
Structure validation
Download full validation report






